Article Details

Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab ...

Retrieved on: 2023-01-12 22:04:24

Tags for this article:

Click the tags to see associated articles and topics

Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab .... View article details on hiswai:

Excerpt

WALTHAM, MA, USA I January 11, 2023 I Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up